CD4+ T cells play distinct roles during the priming versus effector phases of immune checkpoint therapy–dependent tumor elimination by CD8+ T cellsSamuel Ameh, Robert D. Schreiber, Ali H. Ellebedy et al.|Cancer Immunology Research|2026Cited by 0